Please login to the form below

Not currently logged in
Email:
Password:

McCann Health appoints London and New York heads

Mark Archer and Jamie Avallone both become managing directors

Consulting at McCann Health Mark ArcherConsulting at McCann Health - part of the McCann Health group - has appointed Mark Archer and Jamie Avallone as managing directors of its London and New York offices, respectively.

Archer (pictured right) joins the recently-launched consultancy from inVentiv Health, where he was executive vice president and global head of business development.

He has over 30 years of industry experience and has held client- and agency-side business development and strategy roles at QuintilesIMS, Sanofi, Roche, Merck & Co and GlaxoSmithKline.

Meanwhile, Avallone previously served as head of advisory services at Manhattan Research, having first joined as a senior digital healthcare analyst in 2010.

Simon Holt, president of Consulting at McCann Health, said: “Both Jamie and Mark could not be joining at a more exciting time.

“Only five months after our launch, Consulting at McCann Health is already disrupting the old consulting model at precisely the time when clients in pharmaceuticals and the life sciences industry are searching for fresh thinking to tackle the business challenges confronting their future.”

13th February 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cello Health

Cello Health are expert navigators, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics